- Home
- TGL vs NXPLW Comparison
TGL vs NXPLW Comparison
Compare TGL & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- NXPLW
- Stock Information
- Founded
- TGL 2020
- NXPLW N/A
- Country
- TGL United States
- NXPLW United States
- Employees
- TGL N/A
- NXPLW 166
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- NXPLW Telecommunications Equipment
- Sector
- TGL Technology
- NXPLW Telecommunications
- Exchange
- TGL Nasdaq
- NXPLW Nasdaq
- Market Cap
- TGL N/A
- NXPLW N/A
- IPO Year
- TGL 2022
- NXPLW N/A
- Fundamental
- Price
- TGL $2.42
- NXPLW $0.15
- Analyst Decision
- TGL
- NXPLW
- Analyst Count
- TGL 0
- NXPLW 0
- Target Price
- TGL N/A
- NXPLW N/A
- AVG Volume (30 Days)
- TGL 6.7M
- NXPLW 6.4K
- Earning Date
- TGL 05-13-2025
- NXPLW 03-31-2025
- Dividend Yield
- TGL N/A
- NXPLW N/A
- EPS Growth
- TGL N/A
- NXPLW N/A
- EPS
- TGL N/A
- NXPLW N/A
- Revenue
- TGL $2,398,398.00
- NXPLW $66,482,000.00
- Revenue This Year
- TGL N/A
- NXPLW N/A
- Revenue Next Year
- TGL N/A
- NXPLW N/A
- P/E Ratio
- TGL N/A
- NXPLW N/A
- Revenue Growth
- TGL N/A
- NXPLW 179.89
- 52 Week Low
- TGL $1.71
- NXPLW $0.25
- 52 Week High
- TGL $300.00
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- TGL 37.02
- NXPLW N/A
- Support Level
- TGL $1.96
- NXPLW N/A
- Resistance Level
- TGL $2.61
- NXPLW N/A
- Average True Range (ATR)
- TGL 0.78
- NXPLW 0.00
- MACD
- TGL 0.15
- NXPLW 0.00
- Stochastic Oscillator
- TGL 26.01
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.